SciClone Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer and infectious diseases. The company operates through two segments: China and Rest of the World including United States. It is a pharmaceutical company with a substantial commercial business in China a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory and central nervous system disorders. Its ZADAXIN (thymalfasin) is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain cancers. The company was founded in 1990 and is headquartered in Foster City, CA.